首页> 外文期刊>Drug Design, Development and Therapy >Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection
【24h】

Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection

机译:马林分枝杆菌:结核分枝杆菌感染的潜在免疫疗法

获取原文
       

摘要

Purpose: The aim of the present study was to investigate the immune response induced by Mycobacterium marinum infection in vitro and the potential of M. marinum as an immunotherapy for M. tuberculosis infection.Methods: The potential human immune response to certain bacillus infections was investigated in an immune cell–bacillus coculture system in vitro. As a potential novel immunotherapy, M. marinum was studied and compared with two other bacilli, Bacillus Calmette-Guérin (BCG) and live attenuated M. tuberculosis. We examined the changes in both the bacilli and immune cells, especially the time course of the viability of mycobacteria in the coculture system and host immune responses including multinuclear giant cell formation by Wright–Giemsa modified staining, macrophage polarization by cell surface antigen expression, and cytokines/chemokine production by both mRNA expression and protein secretion.Results: The M. marinum stimulated coculture group showed more expression of CD209, CD68, CD80, and CD86 than the BCG and M. tuberculosis (an attenuated strain, H37Ra) groups, although the differences were not statistically significant. Moreover, the M. marinum group expressed more interleukin (IL)-1B and IL-12p40 on day 3 (IL-1B: P = 0.003 and 0.004, respectively; IL-12p40: P = 0.001 and 0.011, respectively), a higher level of CXCL10 on day 1 (P = 0.006 and 0.026, respectively), and higher levels of chemokine (C-X-C motif) ligand (CXCL) 8 and chemokine (C motif) ligand (XCL) 1 on day 3 (CXCL8: P = 0.012 and 0.014, respectively; XCL1: P = 0.000 and 0.000, respectively). The M. marinum stimulated coculture group also secreted more tumor necrosis factor (TNF)-α, IL-1?, and IL-10 on day 1 (TNF-α: P = 0.000 and 0.000, respectively; IL-1?: P = 0.000 and 0.000, respectively; IL-10: P = 0.002 and 0.019, respectively) and day 3 (TNF-α: P = 0.000 and 0.000, respectively; IL-1?: P = 0.000 and 0.001, respectively; IL-10: P = 0.000 and 0.000, respectively). In addition, the colony-forming units (an index of viability) of M. marinum in the M. marinum stimulated coculture group was significantly less than that of BCG and H37Ra in their corresponding bacillus stimulated groups (P = 0.037 and 0.013, respectively).Conclusion: Our results indicated that M. marinum could be a potentially safe and effective immunotherapy.
机译:目的:本研究的目的是研究由海洋分枝杆菌感染引起的免疫应答,以及海分枝杆菌作为结核分枝杆菌感染的免疫疗法的潜力。方法:研究了人类对某些细菌感染的潜在免疫反应。在体外免疫细胞-细菌共培养系统中。作为一种潜在的新型免疫疗法,研究了海藻支原体,并将其与另外两种杆菌卡介苗(BCG)和减毒活结核分枝杆菌进行了比较。我们检查了细菌和免疫细胞的变化,尤其是共培养系统中分枝杆菌生存力的时间进程以及宿主的免疫反应,包括赖特-吉姆萨修饰染色形成的多核巨细胞,细胞表面抗原表达引起的巨噬细胞极化,以及结果:尽管比卡介苗和结核分枝杆菌(减毒株,H37Ra)组,海藻支原体刺激的共培养组的CD209,CD68,CD80和CD86的表达更多。差异无统计学意义。此外,海藻分枝杆菌组在第3天表达更多的白介素(IL)-1B和IL-12p40(IL-1B:P = 0.003和0.004; IL-12p40:P = 0.001和0.011),更高第1天的CXCL10水平(分别为P = 0.006和0.026),第3天的趋化因子(CXC基序)配体(CXCL)8和趋化因子(C基序)配体(XCL)1较高(CXCL8:P = 0.012和0.014; XCL1:P分别为0.000和0.000)。海藻分枝杆菌刺激的共培养组在第1天也分泌了更多的肿瘤坏死因子(TNF)-α,IL-1α和IL-10(TNF-α:P = 0.000和0.000;IL-1α:P分别为0.000和0.000; IL-10:分别为0.002和0.019)和第3天(TNF-α:分别为0.000和0.000;IL-1α:分别为0.000和0.001; IL- 10:分别为P = 0.000和0.000)。此外,海藻分枝杆菌刺激的共培养组中海藻分枝杆菌的菌落形成单位(生存力指数)显着小于其相应芽孢杆菌刺激组中的BCG和H37Ra(分别为P = 0.037和0.013)结论:我们的研究结果表明,M。marinum可能是一种潜在的安全有效的免疫疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号